Dive: W/ AstraZeneca, a Wee1 inhibitor, combine with PARP inhibitor for SCLC. In CDX3, efficacy shown. Mice: 1y SCLC survivor! #ESHG2016

12:45pm May 22nd 2016 via Hootsuite